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Copyright © 200? JCBN Summary Chronic exposure to elevated levels of free fatty acids (FFA) causes β-cell dysfunction
and may induce β-cell apoptosis in type 2 diabetes. The execution of β-cell apoptosis occurs
through activation of mitogen-activated protein kinases (MAPKs). Ginsenoside Rg3 (Rg3), one
of the active ingredients of ginseng saponins, has not been known about the effects on β-cell
apoptosis mediated with FFA. The aims of this study were to investigate the in vitro protective
effects of Rg3 on MIN6N8 mouse insulinoma β-cells against FFA-induced apoptosis, as well as
the modulating effects on p44/42 MAPK activation. Our results showed that Rg3 inhibited the
palmitate-induced apoptosis through modulating p44/42 MAPK activation. We conclude that
Rg3 has the potential role in suppressing the progression of type 2 diabetes by inhibiting
FFA-mediated loss of β-cells.
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Introduction
Increased free fatty acids (FFA), alone or in conjunction
with hyperglycemia, have been proposed to trigger β-cell
loss in type 2 diabetes [1] and moreover, in vitro studies have
demonstrated that long-term exposure to FFA can induce β-
cell death in culture and in isolated islets [2]. The death was
mainly apoptotic with cytochrome c release, caspase-3 acti-
vation, and DNA fragmentation [2–4]. Especially, saturated
fatty acids like palmitic and stearic acids, were found to be
generally cytotoxic to β-cells, whereas unsaturated fatty
acids like linoleic, oleic, and palmitoleic acids, were not, and
even protected cells from saturated FFA-induced apoptosis
[5].
Cells recognize and respond to extracellular stimuli by
engaging specific intracellular programs, such as the sig-
naling cascade that leads to activation of the mitogen-
activated protein kinases (MAPKs) [6]. P44/42 MAPK or
extracellular-regulated protein kinases (ERK), one of MAPK
family, is generally activated by mitogens and survival
factors [7]. Therefore, selective activation of p44/42 can
prevent apoptosis and ensures cell survival in several cell
systems [7]. It should be emphasized, however, that the
anti-apoptotic role of p44/42 MAPK is not absolute.
Ginseng (the root of Panax ginseng C.A. Meyer, family
Aralianceae) has been used clinically to treat type 2 diabetes
[8–9] and has also been used as a tonic, often taken for years
without evidence of adverse effects or toxicity [10–11]. In
recent years, accumulating evidence in vitro and in vivo has
shown that ginseng and its extracts possess anti-diabetic
activities [12–16]. The effects of ginseng might be attribut-
able to its major ginsenoside constituents. However, little
information is available about the effect of ginsenoside Rg3
(20-S-protopanaxadiol-3-[O-β-D-glucopyranosyl (1→2)-β-
glucopyranoside]) (Rg3) on FFA-induced apoptosis in β-cells.
This study was designed to investigate whether Rg3
could mediate protective effects against palmitate-induced
apoptosis, and whether Rg3 could modulate p44/42 MAPK
activation in MIN6N8 mouse insulinoma β-cells.Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis
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Materials and Methods
Cell cultures and palmitate treatment
As a model of pancreatic β-cells, SV40 T-transformed
insulinoma cells derived from nonobese diabetic (NOD)
mice were used (MIN6N8). The cells were kindly provided
by Prof. Myung-Shik Lee (Sungkyunkwan University
School of Medicine, Seoul, Korea) under the permission of
Prof. Junichi Miyazaki (Osaka University, Osaka, Japan)
[17]. Cells were grown in Dulbecco’s modified Eagle’s
medium (DMEM) containing 15% fetal bovine serum,
2 mM glutamine, 100 IU/ml penicillin, and 100 μg/ml
streptomycin. Reagents were obtained from the following
sources: high glucose DMEM, FBS, trypsin-EDTA 100 IU/
ml, penicillin and 100 μg/ml streptomycin from Gibco
(Grand Island, NY). Sodium carbonate, β-mercaptoethanol,
and sodium palmitate from Sigma-Aldrich Corp. (St. Louis,
MO). Palmitate-mediated apoptosis was induced by incuba-
tion with 500 μM palmitate for 48 h. The choice of palmitate
concentration and incubation time was based on the pre-
liminary study.
Rg3 administration
Rg3 was purchased from Fleton Reference Substance
Co., Ltd (Huaishu, Chengdu, China). Rg3 was administrated
simultaneously with palmitate.
Cell viability assay
Cell viability was determined by the reduction of yellow
3-(4,5-dimethylthaizol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT; Sigma) into a purple formazane product by
mitochondrial dehydrogenase of metabolically active cells.
Briefly, cells were seeded at a density of 2 × 106 cells/well
into 96-well plate. After overnight growth, cells were treated
with palmitate and Rg3 for 48 h. The final concentrations of
DMSO in the culture medium were <0.1%. At the end of
treatment, 30 μl of MTT was added, and cells were incu-
bated for a further 4 h. Cell viability was obtained by
scanning with an Enzyme-Linked Immunosorbent Assay
(ELISA) reader with a 570 nm filter [18].
Apoptosis assay
For quantitative determination of apoptotic cell death,
cytoplasmic histone-associated DNA fragments were mea-
sured with the Cell Death Detection ELISA kit from Roche
(Mannheim, Germany) according to the manufacture’s
instructions. This assay is based on a quantitative sandwich
enzyme immunoassay principle, using mouse monoclonal
antibodies directed against DNA and histones. This allows
the specific determination of mono- and oligonucleosomes
but not free histone or DNA that may generate during
nonapoptotic cell death [19] in the cytoplasmic fraction of
cell lysates. At the end of the culture period, cells were
washed with phosphate-buffered saline (PBS), lysed
according to the manufacturer’s protocol, centrifuged
(200 × g, 10 min), placed in a streptavidin-coated microtiter
plate, and incubated with a mixture of antihistone (biotin-
labeled) and anti-DNA (conjugated with peroxidase) anti-
bodies. After removal of the unbound antibodies by a
washing step, the amount of nucleosomes was quantified
photometrically by the peroxidase retained in the immuno-
complex.
Preparation of cell lysates and immunoblotting
Treated cells were harvested after centrifugation at 4°C,
then washed with ice-cold PBS, and immediately lysed in
lysis buffer (cellLytic MT Mammalian Tissue lysis/extrac-
tion reagent, Sigma) for 30-min vortex at 4°C. After centri-
fugation at 13,000 × g at 4°C for 20 min to separate the
cellular debris, the supernatant was collected and stored at
−70°C until use. The protein concentrations were deter-
mined using an assay kit for protein determination (Quick
Start Bradford Dye Reagent; Bio-Rad Laboratories,
Richmond, CA) according to the manufacturer’s instruc-
tions. SDS-PAGE was performed in 10% polyacrylamide
gels loading equal amount of proteins per lane. Proteins
were then transferred to immunoblot PVDF membranes
(Bio-Rad) in Tris-borate-EDTA buffer at 100 V for 1 h. The
membrane was blocked with 5% non-fat milk in TBST
buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, and 0.01%
Tween 20) for 1 h. Membranes were incubated for 4 h at
room temperature with primary antibodies (diluted 1:200–
1:1000). The antibodies against polyclonal p-44/42 MAPK
and phosphorylated p-44/42 MAPK was purchased from
Cell Signaling Technology (Beverly, MA). The antibodies
against cleaved PARP and β-actin was purchased from
Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Secondary
antibodies were obtained from Vector Laboratories
(Burlingame, CA); horseradish peroxidase-conjugated anti
goat or anti rabbit, and exposed to an enhanced chemilumi-
nescence (ECL) detection system (Amersham Pharmacia
Biotech., Piscataway, NJ). Immunoblots were analyzed with
a GS-800 calibrated densitometer (Bio-Rad).
Statistical analyses
Experiments were performed in triplicate and replicated
three times. All values were expressed as mean and standard
deviations (S.D.). One-way analysis of variance (ANOVA)
followed by Duncan’s multiple range test were used for
statistical analyses (SAS software, SAS Inc., Cary, NC).
Results
Ginsenoside Rg3 attenuated palmitate-induced cytotoxicity
in MIN6N8 cells
We first examined the effects of Rg3 on the cell viabilityK. Kim et al.
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of MIN6N8 cells using the MTT assay. Cells treated with
500 μM palmitate for 48 h reduced cell viability by approxi-
mately 50% relative to the palmitate-untreated cells. This
cytotoxic effect was attenuated by co-treatment with Rg3 in
1–5 μM in part dose-dependently (Fig. 1A). Palmitate-
untreated cells administered with 1–5 μM Rg3 showed no
difference on cell viability from that of the palmitate-
untreated control cells (not shown in data).
Ginsenoside Rg3 reduced palmitate-induced apoptosis
Next, we measured nucleosomal release as an early
biochemical feature and quantitative marker of apoptosis
[20]. Incubating the cells with 500 μM palmitate resulted
in an enrichment of mono- and oligonucleosomes in the
cytoplasm due to the DNA degradation by 4.3 fold compared
to palmitate-untreated control (Fig. 1B). The palmitate-
mediated nucleosomal release was significantly inhibited
by the co-treatment with Rg3 at the concentration of 1–5 μM
in part dose-dependently (Fig. 1B).
Ginsenoside Rg3 suppressed palmitate-induced cleavage of
PARP
To investigate the underlying mechanisms for protection
by Rg3 against palmitate-induced apoptosis, we analyzed
whether poly (ADP-ribose) polymerase (PARP) were
involved in this process. PARP (116 kDa) is cleaved to
produce an 89 kDa fragment during apoptosis. When
MIN6N8 cells were incubated with 500 μM palmitate for
48 h, PARP cleavage, as evidenced by accumulation of
89 kDa species, was noted (Fig. 2A). The activation of
PARP was significantly recovered by co-treatment with
Rg3 at 0.1–5.0 μM (Fig. 2).
Ginsenoside Rg3 suppressed palmitate-induced activation
of p44/42 MAPK
When MIN6N8 cells were incubated with 500 μM
palmitate and analyzed over a 48-h, p44/42 MAPK activa-
tion, as evidenced by phosphorylation of what appeared to
be two isoforms, was noted at 48 h after administration with
palmitate (Fig. 3A). To explore the involvement of p44/42
MAPK in the mechanism of protection by Rg3, we examined
the effects of Rg3 on palmitate-mediated p44/42 MAPK
Fig. 1. (A) Effect of ginsenoside Rg3 on cell viability in
palmitate-treated MIN6N8 cells. The cells were treated
with 500 μM palmitate in the presence or absence of
1–5 μM Rg3 for 48 h. Cell viability was determined by
MTT assay. Values are means ± SD (n = 9). Means
with different letters differ significantly among groups
(p<0.05). (B) Effect of Rg3 on palmitate-induced
apoptosis in MIN6N8 cells. The cells were treated with
Rg3 simultaneously with palmitate for 48 h. Apoptosis
was determined as the amount of cytosolic histone-
associated DNA fragments. Values are means ± SD
(n = 9). Means with different letters differ significantly
among groups (p<0.05).
Fig. 2. Effect of ginsenoside Rg3 on palmitate-induced cleavage
of PARP in MIN6N8 cells. Cells were incubated with
500 μM palmitate in the presence or absence of Rg3
(0.1–5.0 μM) for 48 h. Cell lysates were subjected to
Western blot analysis for cleaved PARP and β-actin. (A)
Results are representative of three independent experi-
ments. (B) Density ratio of cleaved PARP/β-actin.
Means with different letters differ significantly among
groups (p<0.05).Ginsenoside Rg3 Suppresses Palmitate-Induced Apoptosis
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activation. Based on the results of Western blot, it was
found that co-treatment of the cells with Rg3 (0.1–5.0 μM)
suppressed palmitate-induced phosphorylation of p44/42
MAPK (Fig. 3B).
Discussion
FFA have been shown to promote a pro-apoptotic effect
on  β-cells [21] that may explain, at least partially, the
elevated rates of β-cell apoptosis and reduction in β-cell
mass seen in diabetes [22]. FFA can affect β-cell apoptosis
directly through the influence on modulating multiple intra-
cellular signaling pathways, or remotely through cytokines
that are secreted by adipose tissues-adipokines [23].
Apoptosis is a highly regulated death process which is
predominant mode of cell death induced by palmitate in
pancreatic  β-cells [24]. The data that we obtained with
MIN6N8 cells indicating that palmitate inhibited the pro-
liferation of the cells, induced an increase of the histone-
associated DNA fragments, and cleaved PARP, are in agree-
ment with an earlier study using the MIN6N8a cells [24].
In the present study, we demonstrated for the first time that
Rg3 protected MIN6N8 pancreatic β-cells against palmitate-
induced apoptotic cell death.
PARP is a DNA repair enzyme that can be activated by
DNA strand breaks [25]. The cleavage of full-length PARP
(116 kDa) to cleaved PARP (89 kDa) serves as a marker of
cell apoptosis [26]. Our study indicated that Rg3-treatment
blocked the cleavage of PARP caused by palmitate in
MIN6N8 cells. Our results suggest that the anti-apoptotic
effect of Rg3 involves the suppression of PARP cleavage.
In contrast to stress-activated protein kinase/c-Jun N-
terminal kinases (SAPK/JNK) and p38, p44/42 MAPK is
usually associated with differentiation and proliferation in
many mammalian cells, including β-cells [27]. P44/42
activity, relative to SAPK/JNK and p38, was unaffected
throughout the stressful procedure for pancreatic islet
transplantation [28]. Meanwhile, several studies show that
the cytotoxic effects of human islet amyloid polypeptide on
rat insulinoma cell lines RINm5F and INS-1E were mediated
by activation of multiple MAPK pathways including p44/42
[29-31]. Interleukin (IL)-1β, an inflammatory cytokine,
induces cell death via activating MAPKs, including SAPK/
JNK, p38 and p44/42 [32]. Interestingly, we showed that
palmitate activated p44/42 MAPK in MIN6N8 cells, and
that co-treatment of Rg3 with palmitate suppressed p44/42
MAPK activation. Our result suggests that palmitate-
induced apoptosis involves the activation of p44/42 MAPK
and that the anti-apoptotic effect of Rg3 involves the
suppression of p44/42 activation.
In conclusion, the present study suggests that Rg3 pro-
tects MIN6N8 pancreatic β-cells against palmitate-induced
apoptosis in part through suppressing PARP cleavage and
p44/42 activation. The results supports the potential role of
Rg3 in suppressing the progression of type 2 diabetes by
inhibiting FFA-mediated loss of pancreatic β-cells.
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